Publications by authors named "Ben Adeyi"

Claim this Profile
T
Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Study.
Richard Weisler, Lawrence Ginsberg, Bryan Dirks, Patrick Deas, Ben Adeyi

J Atten Disord· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years.
Frank A López, Ann Childress, Ben Adeyi, Bryan Dirks, Thomas Babcock

J Atten Disord· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate.
Peter Nagy, Alexander Häge, David R Coghill, Beatriz Caballero, Ben Adeyi

Eur Child Adolesc Psychiatry· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder.
Tobias Banaschewski, Mats Johnson, Michel Lecendreux, Alessandro Zuddas, Ben Adeyi

CNS Drugs· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.
Ralf W Dittmann, Esther Cardo, Peter Nagy, Colleen S Anderson, Ben Adeyi

CNS Drugs· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial.
David R Coghill, Tobias Banaschewski, Michel Lecendreux, César Soutullo, Alessandro Zuddas, Ben Adeyi

Neuropsychiatr Dis Treat· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of ADHD symptoms and global illness severity in adults treated with lisdexamfetamine dimesylate.
Richard H Weisler, Thomas Babcock, Ben Adeyi, Matthew Brams

Postgrad Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial.
Ann C Childress, Valerie Arnold, Ben Adeyi, Bryan Dirks, Thomas Babcock

J Atten Disord· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder.
Tobias Banaschewski, César Soutullo, Michel Lecendreux, Mats Johnson, Alessandro Zuddas, Ben Adeyi

CNS Drugs· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes with lisdexamfetamine dimesylate in children who have attention-deficit/hyperactivity disorder with emotional control impairments.
Alain Katic, Bryan Dirks, Thomas Babcock, Brian Scheckner, Ben Adeyi

J Child Adolesc Psychopharmacol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults.
James Ermer, Mary B Haffey, Cynthia Richards, Kenneth Lasseter, Ben Adeyi

Neuropsychiatr Dis Treat· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder and recent methylphenidate use.
Rakesh Jain, Thomas Babcock, Teodor Burtea, Bryan Dirks, Ben Adeyi

Adv Ther· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parent-reported executive function behaviors and clinician ratings of attention-deficit/hyperactivity disorder symptoms in children treated with lisdexamfetamine dimesylate.
Robert L Findling, Ben Adeyi, Bryan Dirks, Thomas Babcock, Brian Scheckner

J Child Adolesc Psychopharmacol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
Greg W Mattingly, Richard H Weisler, Joel Young, Ben Adeyi, Bryan Dirks

BMC Psychiatry· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study.
Thomas Babcock, Bryan Dirks, Ben Adeyi, Brian Scheckner

BMC Pharmacol Toxicol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically relevant changes in emotional expression in children with ADHD treated with lisdexamfetamine dimesylate.
Alain Katic, Lawrence Ginsberg, Rakesh Jain, Ben Adeyi, Bryan Dirks

J Atten Disord· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attention deficit hyperactivity disorder subtypes and symptom response in adults treated with lisdexamfetamine dimesylate.
Greg Mattingly, Richard Weisler, Bryan Dirks, Thomas Babcock, Ben Adeyi

Innov Clin Neurosci· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults.
Thomas E Brown, Matthew Brams, Maria Gasior, Ben Adeyi, Thomas Babcock

Curr Med Res Opin· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex subgroup analysis of treatment response to lisdexamfetamine dimesylate in children aged 6 to 12 years with attention-deficit/hyperactivity disorder.
James J McGough, Michael Greenbaum, Ben Adeyi, Thomas Babcock, Brian Scheckner

J Clin Psychopharmacol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis.
Rakesh Jain, Thomas Babcock, Teodor Burtea, Bryan Dirks, Ben Adeyi

Child Adolesc Psychiatry Ment Health· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity.
Lawrence Ginsberg, Alain Katic, Ben Adeyi, Bryan Dirks, Thomas Babcock

Curr Med Res Opin· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorder.
James C Ermer, Ben A Adeyi, Michael L Pucci

CNS Drugs· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day.
Sharon B Wigal, Scott H Kollins, Ann C Childress, Ben Adeyi

Child Adolesc Psychiatry Ment Health· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.
Atilla Turgay, Lawrence Ginsberg, Elias Sarkis, Rakesh Jain, Ben Adeyi

J Child Adolesc Psychopharmacol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life.
Stan L Block, Timo Vesikari, Michelle G Goveia, Stephen B Rivers, Ben A Adeyi

Pediatrics· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis